CompletedPhase 1ACTRN12605000523606
A Phase I Study to Determine the Pharmacokinetics of Nestorone Delivered with the Metered Dose Transdermal System (MDTS) in Postmenopausal Women, to be used in contraception
Sponsor
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
Enrollment
6 participants
Start Date
Aug 1, 2004
Study Type
Interventional
Conditions
Eligibility
Sex: FemalesMin Age: 18 Yearss
Plain Language Summary
Simplified for easier understanding
This is an early-phase study looking at: A Phase I Study to Determine the Pharmacokinetics of Nestorone Delivered with the Metered Dose Transdermal System (MDTS) in Postmenopausal Women, to be used in contraception. It may be open to women aged 18 and older. Key requirements include: Healthy post-menopausal women Participation typically involves medical assessments and follow-up visits as part of the research.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Nestorone Metered Dose Transdermal System (MDTS), 6 days.
Nestorone Metered Dose Transdermal System (MDTS), 6 days.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000523606
Related Trials
Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women
NCT069096951 location
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
NCT054445828 locations
Kuwa Free! - Live Free!
NCT050449621 location
Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study
NCT063455601 location
Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study
NCT063455861 location